15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering AstraZeneca PLC, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 8% this year and 6% next.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to AstraZeneca PLC.
As of Sep, 2 of 2 firms rate AZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AZN EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 9 analysts
Next period, 9 analysts expect AstraZeneca PLC to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $10.05, growing to $11.36 the year after.
REVENUE · NEXT QUARTER
$16.6B
Range $16.2B – $16.9B · 9 analysts · +6% YoY
Revenue is expected to reach $16.6B (range $16.2B – $16.9B), +6.0% year-over-year. Full-year consensus is $63.2B, rising to $66.9B next year.
Top analysts covering AstraZeneca PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AZN.
#1
MW
Matthew Weston
UBS
Buy
$17600.00+10896.9% to target
Coverage
—
+ Follow
#2
RS
Rajan Sharma
Goldman Sachs
Buy
$16300.00+10084.6% to target
Coverage
—
+ Follow
#3
GP
Graham Parry
Citi
Buy
$178.00+11.2% to target
Coverage
—
+ Follow
#4
SJ
Sachin Jain
Bank of America Securities
Buy
$16500.00+10209.6% to target
Coverage
—
+ Follow
#5
ML
Michael Leuchten
Jefferies
Buy
$175.00+9.3% to target
Coverage
—
+ Follow
AZN stock forecast FAQ
Is AZN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover AZN?+
2 analysts have an active rating on AstraZeneca PLC.
Who is the most accurate analyst covering AZN?+
Among analysts who currently cover AZN, Matthew Weston of UBS has the strongest overall Quantellect track record. Their current call is Buy with a $17600.00 target.
What is AstraZeneca PLC's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 9 analysts. Full-year EPS is projected at $10.05, rising to $11.36 the following year.
How much revenue is AstraZeneca PLC expected to report next quarter?+
Consensus revenue is $16.6B (range $16.2B – $16.9B). Full-year revenue is projected at $63.2B, growing to $66.9B next year.
Have analysts been upgrading or downgrading AZN lately?+
As of Sep, 2 of 2 firms rate AZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AZN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
